Your browser doesn't support javascript.
loading
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
Boekel, Laura; Atiqi, Sadaf; Leeuw, Maureen; Hooijberg, Femke; Besten, Yaëlle R; Wartena, Rosa; Steenhuis, Maurice; Vogelzang, Erik; Webers, Casper; Boonen, Annelies; Gerritsen, Martijn; Lems, Willem F; Tas, Sander W; van Vollenhoven, Ronald F; Voskuyl, Alexandre E; van der Horst-Bruinsma, Irene; Nurmohamed, Mike; Rispens, Theo; Wolbink, Gertjan.
Affiliation
  • Boekel L; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Atiqi S; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Leeuw M; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Hooijberg F; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Besten YR; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Wartena R; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Steenhuis M; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Vogelzang E; Department of Medical Microbiology and Infection Control, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Webers C; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Boonen A; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
  • Gerritsen M; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Lems WF; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
  • Tas SW; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • van Vollenhoven RF; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Voskuyl AE; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • van der Horst-Bruinsma I; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Nurmohamed M; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Rispens T; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Wolbink G; Department of Rheumatic Diseases, Radboud, University Medical Center, Nijmegen, Netherlands.
Lancet Rheumatol ; 5(7): e375-e385, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37398978
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Language: En Journal: Lancet Rheumatol Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Language: En Journal: Lancet Rheumatol Year: 2023 Type: Article Affiliation country: Netherlands